NEWRegulation

Collegium Pharmaceutical (COLL) Forms DEF 14A Filing on April 10

Published on 4/10/2026

#COLL#SEC#shareholder#filing#governance
Collegium Pharmaceutical (COLL) Forms DEF 14A Filing on April 10

AI Summary

Collegium Pharmaceutical (COLL) has filed a DEF 14A with the SEC dated April 10. This filing includes essential information regarding upcoming shareholder meetings and proposals for the company's governance. It is a standard procedure in ensuring compliance with regulatory requirements. Market participants will review this filing to assess any potential impacts on shareholder relations or corporate strategy.

Source: Read original article (opens in new tab)

Related News

Third Point Exits CoStar (CSGP) Position Without Proxy Fight
M&A

Third Point Exits CoStar (CSGP) Position Without Proxy Fight

Apr 11

Kalshi secures temporary halt after CFTC intervention
Regulation

Kalshi secures temporary halt after CFTC intervention

Apr 11

IBM (IBM) Settles DEI Allegations for $17 Million
Regulation

IBM (IBM) Settles DEI Allegations for $17 Million

Apr 11

Establishment Labs (ESTA) DEF 14A Filing Reported for April 10
Regulation

Establishment Labs (ESTA) DEF 14A Filing Reported for April 10

Apr 10